CompoAtlas

OEMINE PROGESTACTIV

Food supplement declared in France, declaration No 2023-5-748, decision dated 16 May 2023

OEMINE PROGESTACTIV (OEMINE) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
OEMINE
Food business operator placing the product on the market
PHYBIO PHARMA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules
Directions for use
2 gélules au coucher du 15eme au 25 eme jour du cycle
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Cycles féminins, Ménopause

Declaration 308672, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Dioscorea villosa L.RhizomeExtrait sec aqueux680 mg
Alchemilla vulgaris L.Parties aériennesExtrait sec aqueux200 mg

Other active ingredients

NamePer day
Hydrolysat enzymatique de protéines de riznot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Oxyde de zincZinc25 mg15 mg

Additives

E1204

Other ingredients

Fagopyrum esculentum Moench

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé pendant la grossesse et l’allaitement. Demander conseil à un professionnel de santé

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : OEMINE

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line